HomeRGNX • NASDAQ
add
Regenxbio Inc
Previous close
$9.49
Day range
$9.10 - $9.61
Year range
$5.04 - $13.48
Market cap
464.73M USD
Avg Volume
625.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 21.36M | -4.20% |
Operating expense | 79.43M | 17.23% |
Net income | -70.87M | -33.75% |
Net profit margin | -331.81 | -39.61% |
Earnings per share | -1.38 | -31.43% |
EBITDA | -59.37M | -14.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 323.30M | 11.34% |
Total assets | 581.03M | 2.05% |
Total liabilities | 367.35M | 66.14% |
Total equity | 213.68M | — |
Shares outstanding | 50.51M | — |
Price to book | 2.24 | — |
Return on assets | -29.52% | — |
Return on capital | -35.43% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -70.87M | -33.75% |
Cash from operations | -49.34M | -8.45% |
Cash from investing | -140.44M | -52,301.49% |
Cash from financing | 139.23M | 1,574.13% |
Net change in cash | -50.55M | 8.45% |
Free cash flow | -24.38M | 11.45% |
About
Founded
2008
Headquarters
Website
Employees
353
